These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15293874)

  • 1. Rotavirus vaccine--AVANT immunotherapeutics/GlaxoSmithKline: 89-12, RIX4414.
    Drugs R D; 2004; 5(2):113-5. PubMed ID: 15293874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rotavirus vaccine AVANT/GlaxoSmithKline.
    Jones T
    Curr Opin Investig Drugs; 2001 Jul; 2(7):893-5. PubMed ID: 11757786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iodine-131 Tositumomab: (131)I-anti-B1 antibody, (131)I-tositumomab, anti-CD20 murine monoclonal antibody-I-131, B1, Bexxar, (131)I-anti-B1 antibody, iodine-131 tositumomab, iodine-131 anti-B1 antibody, tositumomab.
    BioDrugs; 2003; 17(4):290-5. PubMed ID: 12899647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live attenuated human rotavirus vaccine, Rotarix.
    Bernstein DI
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):188-94. PubMed ID: 17055369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical review on a globally-licensed, live, orally-administrable, monovalent human rotavirus vaccine: Rotarix.
    Nakagomi T; Nakagomi O
    Expert Opin Biol Ther; 2009 Aug; 9(8):1073-86. PubMed ID: 19591630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of a three dose and five dose oral human rotavirus vaccine (RIX4414) schedule in south Indian infants.
    Kompithra RZ; Paul A; Manoharan D; Babji S; Sarkar R; Mathew LG; Kang G
    Vaccine; 2014 Aug; 32 Suppl 1():A129-33. PubMed ID: 25091666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on Rotarix: an oral human rotavirus vaccine.
    O'Ryan M; Linhares AC
    Expert Rev Vaccines; 2009 Dec; 8(12):1627-41. PubMed ID: 19943758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and safety of the human rotavirus vaccine Rotarix co-administered with routine infant vaccines following the vaccination schedules in Europe.
    Vesikari T; Karvonen A; Prymula R; Schuster V; Tejedor JC; Thollot F; Garcia-Corbeira P; Damaso S; Han HH; Bouckenooghe A
    Vaccine; 2010 Jul; 28(32):5272-9. PubMed ID: 20538094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 2 different regimens for reactogenicity, safety, and immunogenicity of the live attenuated oral rotavirus vaccine RIX4414 coadministered with oral polio vaccine in South African infants.
    Steele AD; Reynders J; Scholtz F; Bos P; de Beer MC; Tumbo J; Van der Merwe CF; Delem A; De Vos B
    J Infect Dis; 2010 Sep; 202 Suppl():S93-100. PubMed ID: 20684724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporation of a rotavirus vaccine into the national immunisation schedule in the United Kingdom: a review.
    Nakagomi O; Iturriza-Gomara M; Nakagomi T; Cunliffe NA
    Expert Opin Biol Ther; 2013 Nov; 13(11):1613-21. PubMed ID: 24088009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants.
    Phua KB; Quak SH; Lee BW; Emmanuel SC; Goh P; Han HH; De Vos B; Bock HL
    J Infect Dis; 2005 Sep; 192 Suppl 1():S6-S16. PubMed ID: 16088807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rotarix in developing countries: paving the way for inclusion in national childhood immunization programs in Africa.
    Pawinski R; Debrus S; Delem A; Smolenov I; Suryakiran PV; Han HH
    J Infect Dis; 2010 Sep; 202 Suppl():S80-6. PubMed ID: 20684722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public health impact of accelerated immunization against rotavirus infection among children aged less than 6 months in the United States.
    Weycker D; Atwood MA; Standaert B; Krishnarajah G
    Hum Vaccin Immunother; 2014; 10(7):2032-8. PubMed ID: 25424813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A live attenuated human rotavirus vaccine.
    Bernstein DI
    Drugs Today (Barc); 2007 May; 43(5):281-91. PubMed ID: 17724495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity, reactogenicity and safety of the human rotavirus vaccine RIX4414 (Rotarix™) oral suspension (liquid formulation) when co-administered with expanded program on immunization (EPI) vaccines in Vietnam and the Philippines in 2006-2007.
    Anh DD; Carlos CC; Thiem DV; Hutagalung Y; Gatchalian S; Bock HL; Smolenov I; Suryakiran PV; Han HH
    Vaccine; 2011 Mar; 29(11):2029-36. PubMed ID: 21256876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rotarix: a rotavirus vaccine for the world.
    Ward RL; Bernstein DI
    Clin Infect Dis; 2009 Jan; 48(2):222-8. PubMed ID: 19072246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rotarix (RIX4414): an oral human rotavirus vaccine.
    O'Ryan M
    Expert Rev Vaccines; 2007 Feb; 6(1):11-9. PubMed ID: 17280473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ISA 247: trans-ISA 247, trans-R 1524, ISA(TX)247, ISAtx 247, ISATx247, LX 211, LX211, R 1524, R-1524.
    Drugs R D; 2007; 8(2):103-12. PubMed ID: 17324008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, reactogenicity and immunogenicity of the human rotavirus vaccine in preterm European Infants: a randomized phase IIIb study.
    Omenaca F; Sarlangue J; Szenborn L; Nogueira M; Suryakiran PV; Smolenov IV; Han HH;
    Pediatr Infect Dis J; 2012 May; 31(5):487-93. PubMed ID: 22228231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.